Biohit Plc - Managers' transactions - Aiolfi

Biohit Oyj 3rd March 2021 at 05.00 pm local time (EET)

Notifying Person

Name: BioBrick S.p.A

Position: Closely associated person

(X) Legal Person

(1): Associated Person

Name: Aiolfi, Franco

Position: Member of the Board

Issuer name: Biohit Plc

LEI: 74370089ATTSNBXJVT29

Notification Type: INITIAL NOTIFICATION

Notification reference: 74370089ATTSNBXJVT29_20210303143253_4

____________________________________________

Transaction date: 2021-03-02

Transaction place: NASDAQ HELSINKI LTD (XHEL)

Instrument: SHARE

ISIN: FI0009005482

Nature of transaction: SUBSCRIPTION

Description of transaction:

Disposal of BioAir S.p.A shares controlled by Franco Aiolfi and subscription of the corresponding amount of shares by Biobrick S.p.A controlled by Franco Aiolfi. Both companies have the same ownership structure.

Transaction details

(1): Volume: 92 807 Price: 2,0800000 EUR

Aggregated Information

(1): Volume: 92 807 Average Price: 2,0800000 EUR

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com